Get Your Team Back to Work

Add COVID-19 Antibody Testing as Part of your Employee Return-to-Work Program

Many companies have implemented antibody testing as part of their phased, employee return-to-work strategy. According to the latest CDC Guidance the presence of antibodies, detectable several weeks after symptom onset, “suggests that infectiousness likely is greatly decreased and that some degree of immunity from future infection has developed”
(Review full Guidance for further details)

Learn about the TestGet the Test

CareStart Rapid Antigen Test

The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers. This product is CLIA waived under FDA/EUA authorization.

The CareStart™ COVID-19 Antigen test is authorized for use using nasopharyngeal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms.

The CareStart™ COVID-19 Antigen test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

The CareStart™ COVID-19 Antigen test is authorized for use in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high, moderate or waived complexity tests.

BioCheck Kits

Our BioCheck kits are used by to detect suspicious powder by hundreds of departments around the US.

OneTest for Cancer

Our cutting-edge OneTest uses AI to help detect many common cancers via a single blood draw.

CoronaCheck Tests

CoronaCheck Tests are a series of serology tests offered and distributed by 20/20 in the US and Canada.
Office Workers